$69.99
0.00 (0%)
ImClone Systems, Inc. (NASDAQ:IMCL.DL)
CAPS Rating:
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for IMCL.DL yet. Tell us why you think IMCL.DL will outperform or underperform the market.
RSS Headlines
Fool UK
